Spinal IgG4-related hypertrophic pachymeningitis with spinal cord compression case report.

[1]  G. M. Allan,et al.  What are the most common conditions in primary care? Systematic review. , 2018, Canadian family physician Medecin de famille canadien.

[2]  P. Faust,et al.  IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity. , 2017, Clinical imaging.

[3]  A. Vaglio,et al.  Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome. , 2017, Autoimmunity reviews.

[4]  T. Mimori,et al.  Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria , 2017, Modern rheumatology.

[5]  M. de Vincentiis,et al.  Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease , 2017, Immunologic research.

[6]  K. Okazaki,et al.  Current Concept of IgG4-Related Disease. , 2017, Current topics in microbiology and immunology.

[7]  B. Radotra,et al.  An orphan disease: IgG4-related spinal pachymeningitis: report of 2 cases. , 2016, Journal of neurosurgery. Spine.

[8]  L. Xia,et al.  IgG4-related spinal pachymeningitis , 2016, Clinical Rheumatology.

[9]  Rui Gu,et al.  Cervicothoracic spinal cord compression caused by IgG4-related sclerosing pachymeningitis: a case report and literature review , 2016, European Spine Journal.

[10]  J. Stone,et al.  International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease , 2015, Arthritis & rheumatology.

[11]  S. Skodda,et al.  Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab , 2015, Journal of Clinical Neuroscience.

[12]  J. Stone,et al.  Rituximab for IgG4-related disease: a prospective, open-label trial , 2015, Annals of the rheumatic diseases.

[13]  S. Ikeda,et al.  Multifocal Fibrosclerosis with Hypertrophic Pachymeningitis and a Soft Tissue Mass around the Thoracic Vertebral Bodies: A Case Report with Review of the Literature. , 2015, Internal medicine.

[14]  秀和 冨本,et al.  下垂体炎，および頭蓋，脊髄肥厚性硬膜炎を呈したIgG4関連疾患 , 2014 .

[15]  J. Stone,et al.  IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. , 2014, JAMA neurology.

[16]  Nir Giladi,et al.  Central nervous system manifestation of IgG4-related disease. , 2014, JAMA neurology.

[17]  H. Nawashiro,et al.  IgG4-Related Intracranial Hypertrophic Pachymeningitis : A Case Report and Review of the Literature , 2014, Journal of Korean Neurosurgical Society.

[18]  C. Briani,et al.  Diagnostic value of IgG4 Indices in IgG4-Related Hypertrophic Pachymeningitis , 2014, Journal of Neuroimmunology.

[19]  C. Doglioni,et al.  Cerebrospinal Fluid Analysis in Immunoglobulin G4-related Hypertrophic Pachymeningitis , 2013, The Journal of Rheumatology.

[20]  J. Stone,et al.  IgG4-Related Disease and Hypertrophic Pachymeningitis , 2013, Medicine.

[21]  D. Sahani,et al.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. , 2012, Arthritis and rheumatism.

[22]  D. Sahani,et al.  Consensus statement on the pathology of IgG4-related disease , 2012, Modern Pathology.

[23]  Michael J Levy,et al.  Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience , 2012, Gut.

[24]  Y. Tajima,et al.  Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions , 2012, BMJ Case Reports.

[25]  J. Stone,et al.  IgG4-related disease. , 2012, The New England journal of medicine.

[26]  J. Stone,et al.  Development of an IgG4-RD Responder Index , 2012, International journal of rheumatology.

[27]  C. Doglioni,et al.  IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. , 2012, Annals of internal medicine.

[28]  K. Tsubota,et al.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2011, Modern rheumatology.

[29]  Hisanori UmeharaKazuichi.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2012 .

[30]  F. Blyth,et al.  The Epidemiology of low back pain. , 2010, Best practice & research. Clinical rheumatology.

[31]  S. Choi,et al.  IgG4-Related Sclerosing Pachymeningitis Causing Spinal Cord Compression , 2010, Neurology.

[32]  M. Lopes,et al.  IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria , 2010, Acta Neuropathologica.

[33]  R. Niska,et al.  National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. , 2010, National health statistics reports.

[34]  J. Chan,et al.  IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. , 2009, American Journal of Surgical Pathology.

[35]  H. Nakajima,et al.  Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis , 2003, Gut.

[36]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.